相关实验视频

Updated: May 26, 2025

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

来自美国的生物活性丰富的纳米纤维通过促进血管生成来增强伤口愈合

Fang Wang¹, Shi-Qi Guo¹, Tao-Hong Su¹

¹Cancer Research Center, the Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine, Nanchang 330004, China.

ACS applied materials & interfaces

|February 24, 2025

概括

新鲜的美国纳米 (F-ACNVs) 通过增强细胞增殖和迁移,促进皮肤伤口愈合. 这些来自昆虫的纳米微粒为皮肤创伤提供了一种新的治疗策略,保留了天然的生物特性.

科学领域:

生物技术和再生医学生物技术和再生医学
来自昆虫的治疗药物
伤口治愈研究研究伤口治愈研究

背景情况:

皮肤创伤会引起严重的疼痛,胀和痕,影响日常生活.
美国的提取物显示出治疗伤口管理的治疗潜力.
传统的基于溶剂的提取可能会降低有益的生物特性.

研究的目的:

研究来自新鲜的美国 (F-ACNVs) 的纳米的治疗疗效,用于皮肤伤口治疗.
分析F-ACNVs的生物特征和活性成分.
评估F-ACNVs对细胞增殖,迁移和皮肤修复的影响.

主要方法:

使用超高速离心法分离新鲜和干燥的美国纳米 (F-ACNV和D-ACNV).
包括代谢学,蛋白学和长非编码RNA (lncRNA) 的F-ACNVs的简介在内的全面的奥米克分析.
在人静脉内皮细胞 (HUVEC) 和人皮皮质皮质细胞 (HACAT) 的体外研究,以及体内皮肤机械创伤模型.

主要成果:

与D-ACNV相比,F-ACNV显示出较高的细胞增殖促进活性.
F-ACNV 含有丰富的代谢产物,蛋白质和 lncRNAs.
F-ACNVs显著增强了HUVEC和HACAT的扩散和迁移,并加速了皮肤机械创伤的修复,可能是通过血管性途径.

结论:

新鲜的美国的纳米片代表了一种有前途的,用于皮肤创伤的新型治疗剂.
保护昆虫衍生材料的内在生物特性对于治疗疗效至关重要.
这项研究强调了昆虫在再生医学中的未开发的药用潜力.

关键词:

美国的.血管新生是因为血管新生.昆虫药物昆虫药物是一种药物.纳米纤维的纳米纤维.皮肤创伤皮肤创伤

更多相关视频

A Full Skin Defect Model to Evaluate Vascularization of Biomaterials In Vivo

A Full Skin Defect Model to Evaluate Vascularization of Biomaterials In Vivo

Published on: August 28, 2014

Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development

Author Spotlight: Investigating Angiogenesis Through Challenges and Innovations in Assay Development

Published on: May 31, 2024

相关概念视频

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...